Trials / Unknown
UnknownNCT05378516
Placental Pathology and Inflammatory Factor Analysis of OAPS
Placental Pathology and Inflammatory Factor Analysis of Obstetric Antiphospholipid Syndrome Patients
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 40 (estimated)
- Sponsor
- Peking University People's Hospital · Academic / Other
- Sex
- Female
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
This investigation is on placental pathological changes and inflammatory factors associated with obstetric antiphospholipid syndrome.
Detailed description
1\. To clarify the correlation between antiphospholipid antibody, ACC1 expression level, Treg cell and placental pathological changes associated with antiphospholipid syndrome. 2. Reveal that antiphospholipid antibodies affect Treg cell differentiation through the key enzyme of lipid metabolism ACC1.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | no intervention | no intervention |
Timeline
- Start date
- 2022-01-01
- Primary completion
- 2022-05-12
- Completion
- 2023-12-31
- First posted
- 2022-05-18
- Last updated
- 2022-05-18
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05378516. Inclusion in this directory is not an endorsement.